YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines
出版年份 2020 全文链接
标题
YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-10
DOI
10.1038/s41598-020-63391-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater
- (2019) Min Hwan Kim et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
- (2019) Xiaodong Feng et al. CANCER CELL
- Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
- (2018) Richard D. Carvajal et al. JOURNAL OF CLINICAL ONCOLOGY
- YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
- (2018) Min Hwan Kim et al. Cancer Immunology Research
- The Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma
- (2018) Martine J. Jager et al. OPHTHALMOLOGY
- Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
- (2018) Yumeng Wang et al. Cell Reports
- Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
- (2017) Kimberly C. Lin et al. NATURE CELL BIOLOGY
- Metastatic disease from uveal melanoma: treatment options and future prospects
- (2016) Richard D Carvajal et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
- (2016) Min Hwan Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Uveal Melanomas with SF3B1 Mutations
- (2016) Serdar Yavuzyigitoglu et al. OPHTHALMOLOGY
- Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice
- (2015) J. L.-Y. Huang et al. CANCER RESEARCH
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
- (2015) M. H. Kim et al. EMBO JOURNAL
- A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma
- (2015) S. E. Hiemer et al. MOLECULAR CANCER RESEARCH
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
- (2014) Diane D. Shao et al. CELL
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
- (2014) Nabil Amirouchene-Angelozzi et al. Molecular Oncology
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More